Participation of protein kinases in the stimulant action of GLP-1 on 2-deoxy-D-glucose uptake by normal rat skeletal muscle

Hormone and Metabolic Research

Volumn 37, Issue 5, 2005, Pages 275-280

  Acitores, A ^a   Gonzalez N ^a   Sancho, V ^a   Arnes L ^a   Valverde, I ^a   Malaisse, W J ^b   Villanueva Penacarrillo M L ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Glucose transport; Protein kinases

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DEOXYGLUCOSE; GLUCAGON LIKE PEPTIDE 1; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; RAPAMYCIN; S6 KINASE; TUMOR NECROSIS FACTOR ALPHA; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; BIOLOGICAL TRANSPORT; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; ENZYME INHIBITORS; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; MUSCLE, SKELETAL; ORGAN CULTURE TECHNIQUES; PEPTIDE FRAGMENTS; PROTEIN KINASES; PROTEIN PRECURSORS; RATS; RATS, WISTAR;

EID: 21244484691     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-861469     Document Type: Article

References (31)

1. Creutzfeldt W. The entero-insular axis in type 2 diabetes. Incretins as therapeutic agents. Exp Clin Endocrinol Diabetes 2001; 109, suppl 2: S288-S303
2. Gutniak M, Orskov C, Holst JJ, Ahrén B, Efendic S. Antidiabetogenic effects of glucagon-like peptide-1(7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 1992; 326: 1316-1322
3. D'Alessio DA, Prigeon RL, Ensinck JW. Enteral enhancement of glucose disposition by both insulin-dependent and insulin-independent processes. A physiological role of glucagon-like peptide 1. Diabetes 1995; 44: 1433-1437
4. Ehlers MR, Klaff LJ, D'Alessio DA, Brazg R, Kay HD, Harley RE, Mathisen AL, Schneider R. Recombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 diabetes. Horm Metab Res 2003; 35: 611-616
5. Valverde I, Morales M, Clemente F, López-Delgado MI, Delgado E, Perea A, Villanueva-Peñacarrillo ML. Glucagon-like peptide-1: a potent glycogenic hormone. FEBS Lett 1994; 349: 313-316
6. Villanueva-Peñacarrillo ML, Alcántara A, Clémente F, Delgado E, Valverde I. Potent glycogenic effect of GLP-1 (7-36) amide in rat skeletal muscle. Diabetologia 1994; 37: 1163-1166
7. Perea A, Viñambres C, Clemente F, Villanueva-Peñacarrillo ML, Valverde I. GLP-1(7-36)amide effects on glucose transport and metabolism in rat adipose tissue. Horm Metab Res 1997; 9: 417-421
8. Villanueva-Peñacarrillo ML, Márquez L, González N, Díaz-Miguel M, Valverde I. Effect of GLP-1 on lipid metabolism in human adipocytes. Horm Metab Res 2001; 33: 73-77
9. Morales M, López-Delgado MI, Alcántara A, Luque MA, Clemente F, Márquez L, Puente J, Viñambres C, Malaisse WJ, Villanueva-Peñacarrillo ML, Valverde I. Preserved GLP-1 effects upon glycogen synthase a activity and glucose metabolism in isolated hepatocytes and skeletal muscle from diabetic rats. Diabetes 1997; 46: 1264-1269
10. Mérida E, Delgado E, Molina LM, Villanueva-Peñacarrillo ML, Valverde I. Presence of glucagon and glucagon-like peptide-1(7-36)amide receptors in solubilized membranes of human adipose tissue. J Clin Endocrinol Metab 1993; 77: 1654-1657
11. Valverde I, Mérida E, Delgado E, Trapote MA, Villanueva- Peñacarrillo ML. Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue. Endocrinology 1993; 132: 75-79
12. Delgado E, Luque MA, Alcántara A, Trapote MA, Clémente F, Galera C, Valverde I, Villanueva-Peñacarrillo ML. Glucagon-like peptide-1 binding to rat skeletal muscle. Peptides 1995; 16: 225-229
13. Villanueva-Peñacarrillo ML, Delgado E, Trapote MA, Alcántara AI, Clemente F, Luque MA, Perea A, Valverde I. Glucagon-like peptide-1 binding to rat hepatic membranes. J Endocrinol 1995; 146: 183-189
14. Yang H, Egan JM, Wang Y, Moyes D, Roth J, Montrose MH, Montrose-Rafizadeh C. GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor. Am J Physiol 1998; 275: C675-C683
15. Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide-1. Proc Natl Acad Sci USA 1992; 89: 8641-8645
16. Luque MA, González N, Márquez L, Acitores A, Redondo A, Morales M, Valverde I, Villanueva-Penacarrillo ML GLP-1 and glucose metabolism in human myocytes. J Endocrinol 2002; 173: 465-473
17. Gonzalez N, Acitores A, Sancho V, Valverde I, Villanueva- Peñacarrillo ML. Effect of GLP-1 on glucose transport and its cell signaling in human myocytes. Regul Pept 2005; 126: 203-211
18. Wang Y, Kole HK, Montrose-Rafizadeh C, Perfetti R, Bernier M, Egan JM. Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions. J Mol Endocrinol 1997; 19: 241-248
19. Villanueva-Peñacarrillo ML, Puente J, Redondo A, Clemente F, Valverde I. Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in NIDDM and IDDM rats. Endocrine 2001; 15: 241-248
20. Acitores A, González N, Sancho V, Valverde I, Villanueva- Peñacarrillo ML. Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle. J Endocrinol 2004; 180: 389-398
21. Redondo A, Trigo MV, Acitores A, Valverde I, Villanueva-Penacarrillo ML. Cell signalling of the GLP-1 action in rat liver. Mol Cell Endocrinol 2003; 204: 43-50
22. Sancho V, Trigo MV, González N, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML. Effects of GLP-1 and exending on kinase activity, 2-deoxy-D-glucose transport, lipolysis and lipogenesis in adipocytes from normal and streptozotocin-induced type 2 diabetic rats. J Mol Endocrinol 2005: in press
23. González N, Sancho V, Martín-Duce A, Torneo-Esteban P, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML. GLP-1 signalling and effects on glucose metabolism in myocytes from type 2 diabetic patients. Submitted for publication
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-254
25. Dohm GL, Tapscott EB, Pories WJ, Dabbs DJ, Flickinger EG, Meelheim TF, Atkinson SM, Elton CW, Caro JF. An in vitro human muscle preparation suitable for metabolic studies.J Clin Invest 1988; 82: 486-494
26. Dent P, Lavoinne A, Nakielny S, Caudwell FB, Watt P, Cohen P. The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 1990; 348: 302-308
27. Lazar DF, Wiese RJ, Brady MJ, Mastick CC, Waters SB, Yamauchi K, Pessin JE, Cuatrecasas P, Saltiel AR. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J Biol Chem 1995; 270: 20801-20807
28. Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase 3. Nature (London) 1995; 378: 785-789
29. Hurel SJ, Rochford JJ, Borthwick AC, Wells AM, Vandenheede JR, Turn-bull DM, Yeaman SJ. Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis. Biochem J 1996; 320: 871-877
30. Peak M, Rochford JJ, Borthwick AC, Yeaman SJ, Agius L. Signalling pathways involved in the stimulation of glycogen synthesis by insulin in rat hepatocytes. Diabetologia 1998; 41: 16-25
31. Ragolia L, Begum N. Protein phosphatase-1 and insulin action. Cell Biochem 1998; 182: 49-58